Aberrant Expression of the NF-κB and IκB Proteins in B Cells from Viable Motheaten Mice

References

• Green M. C., Shultz L. D. Motheaten an immunodeficient mutant of the mouse. I. Genetics and pathology. J. Hered. 1975; 66: 250–258
   PubMed Web of Science ®Google Scholar
• Shultz L. D., Coman D. R., Bailey C. L., Beamer W. G., Sidman C. L. “Viable motheaten,” a new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 1984; 116: 179–192
   PubMed Web of Science ®Google Scholar
• Sidman C. L., Shultz L. D., Unanue E. R. The mouse mutant “motheaten”. II. Functional studies of the immune system. J. Immunol. 1978; 121: 2399–2404
   PubMed Web of Science ®Google Scholar
• Mc Coy K. L., Engel D., Clagett J. Accelerated rate of mononuclear phagocyte production in vitro by splenocytes from autoimmune motheaten mice. Am. J. Pathol. 1983; 112: 18–26
   PubMed Web of Science ®Google Scholar
• Greiner D. L., Goldschneider I., Komschlies K. L., Medlock E. S., Bollum F. J., Schultz L. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells. J. Exp. Med. 1986; 164: 1129–1140
   PubMed Web of Science ®Google Scholar
• Ddvidson W. F., Morse H. C., Sharrow S. O., Chused T. M. Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J. Immunol. 1979; 122: 884–891
   PubMed Web of Science ®Google Scholar
• Clark E. A., Shultz L. D., Pollack S. B. Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics 1981; 12: 601–613
   PubMed Web of Science ®Google Scholar
• Shultz L. D., Schweitzer P. A., Rajan T. V., Yi T., Ihle J. N., Matthews R. J., Thomas M. L., Beier D. R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445–1454
   PubMed Web of Science ®Google Scholar
• Kozlowski M., Mlinarie Rascan I., Feng G. S., Shen R., Pawson T., Siminovitch K. A. Expression and catalytic activity of the tyrosine phosphatase PTPIC is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 1993; 178: 2157–2163
   PubMed Web of Science ®Google Scholar
• Tsui F. W., Tsui H. W. Molecular basis of the motheaten phenotype. Immunol. Rev. 1994; 138: 185–206
   PubMed Web of Science ®Google Scholar
• Thomas M. L. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor [comment]. J. Exp. Med. 1995; 181: 1953–1956
   PubMed Web of Science ®Google Scholar
• Pani G., Kozlowski M., Cambier J. C., Mills G. B., Siminovitch K. A. Identification of the tyrosine phosphatase PTPIC as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling [see comments]. J. Exp. Med. 1995; 181: 2077–2084
   PubMed Web of Science ®Google Scholar
• Cyster J. G., Goodnow C. C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995; 2: 13–24
   PubMed Web of Science ®Google Scholar
• Lankester A. C., van Schijndel G. M., van Lier R. A. Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation. J. Biol. Chem. 1995; 270: 20305–20308
   PubMed Web of Science ®Google Scholar
• De Franco A. L., Law D. A. Tyrosine phosphatases and the antibody response [comment]. Science 1995; 268: 263–264
   PubMed Web of Science ®Google Scholar
• David M., Chen H. E., Goelz S., Larner A. C., Neel B. G. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTPI. Mol. Cell Bid. 1995; 15: 7050–7058
   Web of Science ®Google Scholar
• D'Amhrosio D., Hippen K. L., Minskoff S. A., Mellman I., Pani G., Siminovitch K. A., Cambier J. C. Recruitment and activation of PTPIC in negative regulation of antigen receptor signaling by Fc gamma RIIBI [see comments]. Science 1995; 268: 293–297
   PubMed Web of Science ®Google Scholar
• Kon Kozlowski M., Pani G., Pawson T., Siminovitch K. A. The tyrosine phosphatase PTPIC associates with Vav, Grb2, and mSosl in hematopoietic cells. J. Bid. Chem. 1996; 271: 3856–3862
   PubMed Web of Science ®Google Scholar
• Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705–716
   PubMed Web of Science ®Google Scholar
• Grilli M., Chiu J. J., Lenardo M. J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Annu. Rev. Immunol. 1993; 143: 1–62
   Google Scholar
• Baldwin A. S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996; 14: 649–683
   PubMed Web of Science ®Google Scholar
• Liou H. C., Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 1993; 5: 477–487
   PubMed Web of Science ®Google Scholar
• Ghosh S., Gifford A. M., Riviere L. R., Tempst P., Nolan G. P., Baltimore D. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 1990; 62: 1019–1029
   PubMed Web of Science ®Google Scholar
• Nolan G. P., Ghosh S., Liou H. C., Tempst P., Baltimore D. DNA binding and 1 kappa B inhibition of the cloned p65 subunit of. Cell 1991; 64: 961–969
   PubMed Web of Science ®Google Scholar
• Gilmore T. D. Malignant transformation by mutant Rel proteins. Trends. Genet. 1991; 7: 318–322
   PubMed Web of Science ®Google Scholar
• Ryseck R. P., Weih F., Carrasco D., Bravo R. RelB, a member of the Rel/NF-kappa B family of transcription factors. Braz. J. Mrd. Bid. Res. 1996; 29: 895–903
   PubMed Web of Science ®Google Scholar
• Perkins N. D., Schmid R. M., Duckett C. S., Leung K., Rice N. R., Nabel G. J. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc. Nail. Acad. Sci. USA 1992; 89: 1529–1533
   PubMed Web of Science ®Google Scholar
• Whiteside S. T., Epinat J. C., Rice N. R., Israel A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 1997; 16: 1413–1426
   PubMed Web of Science ®Google Scholar
• Verma I. M., Stevenson J. K., Schwarz E. M., Van Antwerp D., Miyamoto S. Rel/NF-kappa B/l kappa B family: intimate tales of association and dissociation. Genes Dev. 1995; 9: 2723–2735
   PubMed Web of Science ®Google Scholar
• Beg A. A., Ruben S. M., Scheinman R. I., Haskill S., Rosen C. A., Baldwin A S., Jr. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention published erratum appears in. Genes Dev. Dec, 1992; 6(12B)2664–5
   Web of Science ®Google Scholar
• Genes Dev. 1992; 6: 1899–1913
   PubMed Web of Science ®Google Scholar
• Baeuerle P. A., Lenardo M., Pierce J. W., Baltimore D. Phorbol-ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex. Cold-Spring Harb. Symp. Quant. Bid. 1988; 53(Pt 2)789–798
   PubMedGoogle Scholar
• Neumann M., Tsapos K., Scheppler J. A., Ross J., Franza B. R., Jr. Identification of complex formation between two intracellular tyrosine kinase substrates: human c-Rel and the p105 precursor of p50 NF-kappa B. Oncogene 1992; 7: 2095–2104
   PubMed Web of Science ®Google Scholar
• Li C. C., Dai R. M., Chen E., Longo D. L. Phosphorylation of NF-KBI-p50 is involved in NF-kappa B activation and stable DNA binding. J. Biol. Chem. 1994; 269: 30089–30092
   PubMedGoogle Scholar
• Finco T. S., Baldwin A. S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995; 3: 263–272
   PubMed Web of Science ®Google Scholar
• Druker B. J., Neumann M., Okuda K., Franza B. R. Jr. and J.D. Griffin. Rel is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils. J. Biol. Chem. 1994; 269: 5387–5390
   PubMed Web of Science ®Google Scholar
• Chen Z., Hagler J., Palombella V. J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995; 9: 1586–1597
   PubMed Web of Science ®Google Scholar
• Chen Z. J., Parent L., Maniatis T. Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996; 84: 853–862
   PubMed Web of Science ®Google Scholar
• Brown K., Gerstberger S., Carlson L., Franzoso G., Siehenlist U. Control of I kappa B-alpha proteolysis by sitc-specific, signal-induced phosphorylation. Science 1995; 267: 1485–1488
   PubMed Web of Science ®Google Scholar
• Huo L., Rothstein T. L. Receptor-specific induction of individual AP-I components in B lymphocytes. J. Immunol. 1995; 154: 3300–3309
   PubMed Web of Science ®Google Scholar
• Huo L., Rothstein T. L. Isolation and characterization of murine fra-I: induction mediated by CD40 and surface Ig is protein kinase C dependent. J. Immunol. 1996; 157: 3812–3818
   PubMed Web of Science ®Google Scholar
• Grumont R. J., Gerondakis S. Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones. Oncogene Res. 1989; 4: 1–8
   PubMedGoogle Scholar
• Ueberla K., Lu Y., Chung E., Haseltine W. A. The NF-kappa B p65 promoter. J. Acquir. Immune. Defic. Syndr. 1993; 6: 227–230
   PubMed Web of Science ®Google Scholar
• Weih F., Carrasco D., Durham S. K., Barton D. S., Ryseck C. A., Ryseck R. P.S.A. Lira and R. Bravo. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 1995; 80: 331–340
   PubMed Web of Science ®Google Scholar
• Baeuerle P. A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev. Immunol. 1994; 12: 141–179
   PubMed Web of Science ®Google Scholar
• Weil R., Laurent Winter C., Israel A. Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha. J. Biol. Chem. 1997; 272: 9942–9949
   PubMedGoogle Scholar
• Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995b; 376: 167–170
   PubMed Web of Science ®Google Scholar
• Doi T. S., Takahashi T., Taguchi O., Azuma T., Obatd Y. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 1997; 185: 953–961
   PubMed Web of Science ®Google Scholar
• Khaled A. R., Butfiloski E. J., Sobel E. S., Schiffenbauer J. Functional consequences of the SHP-1 defect in motheaten viable mice-role of NF-kappaB. Cellular Immunol. 1998, In press
   PubMed Web of Science ®Google Scholar
• Klement J. F., Rice N. R., Car B. D., Abbondanzo S. J., Powers G. D., Bhatt P. H., Chen C. H., Rosen C. A., Stewart C. L. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol. Cell Biol. 1996; 16: 2341–2349
   PubMed Web of Science ®Google Scholar
• Beg A. A., Sha W. C., Bronson R. T., Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 1995a; 9: 2736–2746
   PubMed Web of Science ®Google Scholar
• Legrand Poels S., Maniglia S., Boclaert J. R., Piette J. Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells. Biochem. Pharmacol 1997; 53: 339–346
   PubMed Web of Science ®Google Scholar
• Desjardin L. E., Butfiloski E. J., Sohel E. S., Schiffenbauer J. Hyperproliferation of BXSB B cells is linked to the Yaa allele. Clin. Immunol. Immunopathol. 1996; 81: 145–152
   PubMedGoogle Scholar
• Liou H. C., Sha W. C., Scott M. L., Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell Biol. 1994; 14: 5349–5359
   PubMed Web of Science ®Google Scholar
• Mc Elhinny J. A., Truslin S. A., Bren G. D., Chester N., Paya C. V. Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell Biol. 1996; 16: 899–906
   PubMed Web of Science ®Google Scholar
• Kretz Remy C., Mehlen P., Mirault M. E., Arrigo A. P. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J. Cell Biol. 1996; 133: 1083–1093
   PubMed Web of Science ®Google Scholar
• Di Donato J. A., Mercurio F., Karin M. Phosphorylation of I kappa B alpha precedes hut is not sufficient for its dissociation from NF-kappa B. Mol. Cell Biol. 1905; 15: 1302–1311
   Google Scholar
• Menon S. D., Guy C. R., Tan Y. H. involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor. J. Biol. Chrin. 1995; 270: 18881–18887
   PubMed Web of Science ®Google Scholar
• Anderson M. T., Staal F. J., Gitler C., Herzenberg L. A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc. Natl. Acad. Sci. USA 1994; 91: 11527–11531
   PubMed Web of Science ®Google Scholar
• Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B., Mueller Dicckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J. F. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 1996; 86: 787–798
   PubMed Web of Science ®Google Scholar
• Natarajan K., Manna S. K., Chaturvedi M. M., Aggarwal B. B. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappa B, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Arch. Biochem. Biophys. 1998; 352: 59–70
   PubMed Web of Science ®Google Scholar
• Lee F. S., Hagler J., Chen Z. J., Maniatis T. Activation of IkappaBalpha kinase complex by MEKKI, a kinase of the JNK pathway. Cell 1997; 88: 213–222
   PubMed Web of Science ®Google Scholar
• Weih F., Warr G., Yang H., Bravo R. Multifocal defects in immune responses in RelB-deficient mice. J Immunol. 1997; 158: 5211–5218
   PubMed Web of Science ®Google Scholar
• SuYang H., Phillips R., Douglas I., Ghosh S. Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol. Cell Bid. 1996; 16: 5444–5449
   Google Scholar